Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Structure Therapeutics Appoints John Berrios As Chief Commercial Officer
PUBLIC · GPCRAug 10, 2026•about 3 hours ago
Position
Chief Commercial Officer
Company
Structure Therapeutics
John Berrios
San FranciscoBiotechnologyTherapeuticsPharmaceuticalBiopharma
Description
Structure Therapeutics has appointed John Berrios as Chief Commercial Officer as it prepares for upcoming aleniglipron clinical trial readouts. This strategic appointment comes amidst a backdrop of increased investor attention and market momentum for the company.
Company Information
Company
Structure Therapeutics
Location
601 Gateway Blvd, Suite 900
San Francisco, California, United States
About
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.
San FranciscoBiotechnologyTherapeuticsPharmaceuticalBiopharma